ABSTRACT
Non-communicable diseases, especially hypertension, are disproportionately problematic in low- and middle-income countries such as Bangladesh, where they have become one of the leading causes of death among its population. The present study compares both the prevalence of hypertension and smoking in employees of Bangladeshi beverage industries to that of the general population. By capitalizing on data from various sources, this research evinces that the prevalence of the preceding issues is disturbingly high, particularly among certain demographics. This, despite the efforts the National Heart Foundation put in place to address the challenges in hypertension screening and management, reflects the need for healthcare delivery. The connection between smoking with health in this sense is confirmed; thus, it will be of crucial necessity to understand the link between these threats, especially within the beverage industry. This study has, therefore, tried to shed light on the nexus, to inform targeted interventions aimed at promoting healthier work environments for the ultimate reduction of NCD-related deaths within the country.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors declare no financial conflicts of interest related to this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by the Research Ethics Committee of North South University, Dhaka, Bangladesh under the approval reference number [#2024/OR-NSU/IRB/0311]. The approval was granted on 2-April-2024. All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The datasets generated and analyzed during the current study are available from the author upon request.
